Article
Applied Clinical Trials
MMS Holdings Inc., a data-focused CRO, announced that the company has assisted Korea-based Vivozon Inc. in achieving a Fast Track Designation from the Food and Drug Administration for VVZ-149, a non-opioid painkiller. Read the full release here.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.